马王堆运动干预对稳定期慢性阻塞性肺疾病患者肺功能、体质和生活质量的影响：一项随机对照试验

IF 3.3 3区医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

Complementary therapies in medicine Pub Date : 2025-03-01 DOI:10.1016/j.ctim.2025.103152

Zhenggang Zhu , Ayu Suzailiana Muhamad , Norsuhana Omar , Foong Kiew Ooi , Xiaoyan Pan , Marilyn Li Yin Ong

{"title":"马王堆运动干预对稳定期慢性阻塞性肺疾病患者肺功能、体质和生活质量的影响：一项随机对照试验","authors":"Zhenggang Zhu , Ayu Suzailiana Muhamad , Norsuhana Omar , Foong Kiew Ooi , Xiaoyan Pan , Marilyn Li Yin Ong","doi":"10.1016/j.ctim.2025.103152","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Physical exercise intervention in pulmonary rehabilitation is recommended to increase strength, endurance, and flexibility in chronic obstructive pulmonary disease (COPD). However, certain physical intervention may be restrictive to COPD patients, as it induces fatigue and shortness of breath. Mawangdui exercise, a low-to-medium-intensity aerobic exercise, has been gaining popularity in China as an adjuvant physical therapy, particularly for patients with contraindications to exercise, to improve their health.</div></div><div><h3>Objective</h3><div>To investigate the effectiveness of the traditional Chinese Mawangdui exercise for patients with COPD in a mild to moderate stable stage.</div></div><div><h3>Methods</h3><div>A total of 54 COPD patients in stable stage (Mawangdui group, n = 27; control group, n = 27) were enroled for a period of 12-weeks. The Mawangdui group practised the Mawangdui exercise, while the control group maintained daily activities without additional exercise. The outcomes measurements were pulmonary function, exercise capacity, back-leg-chest muscle strength, sit-and-reach flexibility, dyspnoea symptoms, and quality of life. The outcomes were assessed at baseline, 24 h, 6 weeks, and 12 weeks post-intervention.</div></div><div><h3>Results</h3><div>Improvements were observed for Borg CR-10 score, SpO<sub>2</sub>, BMI, body fat%, fat mass, flexibility mMRC, and SGRQ scores (<em>p</em> < 0.05) at 12 weeks. At week 12, Mawangdui group showed improved exercise capacity (6MWT mean difference 63.39 m, CI 48.36－78.40), back-leg-chest muscle strength (mean difference 5.92 kg, CI −2.57－-14.41), and dyspnoea (CAT score mean difference −5.50, CI −6.42－-4.59) in per-protocol population. However, FEV<sub>1</sub>, FVC, FEV<sub>1</sub>% pred, and fat-free mass did not show improvements with Mawangdui exercise.</div></div><div><h3>Conclusion</h3><div>COPD patients in stable stage who performed Mawangdui exercise for 12 weeks improved exercise capacity, dyspnoea, muscle strength, flexibility, BMI, body fat%, fat mass and quality of life. Therefore, Mawangdui exercise is recommended for COPD patients in the stable stage to improve physical fitness and quality of life.</div></div>","PeriodicalId":10545,"journal":{"name":"Complementary therapies in medicine","volume":"89 ","pages":"Article 103152"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Mawangdui exercise intervention on the pulmonary function, physical fitness and quality of life in stable chronic obstructive pulmonary disease patients: A randomised controlled trial\",\"authors\":\"Zhenggang Zhu , Ayu Suzailiana Muhamad , Norsuhana Omar , Foong Kiew Ooi , Xiaoyan Pan , Marilyn Li Yin Ong\",\"doi\":\"10.1016/j.ctim.2025.103152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Physical exercise intervention in pulmonary rehabilitation is recommended to increase strength, endurance, and flexibility in chronic obstructive pulmonary disease (COPD). However, certain physical intervention may be restrictive to COPD patients, as it induces fatigue and shortness of breath. Mawangdui exercise, a low-to-medium-intensity aerobic exercise, has been gaining popularity in China as an adjuvant physical therapy, particularly for patients with contraindications to exercise, to improve their health.</div></div><div><h3>Objective</h3><div>To investigate the effectiveness of the traditional Chinese Mawangdui exercise for patients with COPD in a mild to moderate stable stage.</div></div><div><h3>Methods</h3><div>A total of 54 COPD patients in stable stage (Mawangdui group, n = 27; control group, n = 27) were enroled for a period of 12-weeks. The Mawangdui group practised the Mawangdui exercise, while the control group maintained daily activities without additional exercise. The outcomes measurements were pulmonary function, exercise capacity, back-leg-chest muscle strength, sit-and-reach flexibility, dyspnoea symptoms, and quality of life. The outcomes were assessed at baseline, 24 h, 6 weeks, and 12 weeks post-intervention.</div></div><div><h3>Results</h3><div>Improvements were observed for Borg CR-10 score, SpO<sub>2</sub>, BMI, body fat%, fat mass, flexibility mMRC, and SGRQ scores (<em>p</em> < 0.05) at 12 weeks. At week 12, Mawangdui group showed improved exercise capacity (6MWT mean difference 63.39 m, CI 48.36－78.40), back-leg-chest muscle strength (mean difference 5.92 kg, CI −2.57－-14.41), and dyspnoea (CAT score mean difference −5.50, CI −6.42－-4.59) in per-protocol population. However, FEV<sub>1</sub>, FVC, FEV<sub>1</sub>% pred, and fat-free mass did not show improvements with Mawangdui exercise.</div></div><div><h3>Conclusion</h3><div>COPD patients in stable stage who performed Mawangdui exercise for 12 weeks improved exercise capacity, dyspnoea, muscle strength, flexibility, BMI, body fat%, fat mass and quality of life. Therefore, Mawangdui exercise is recommended for COPD patients in the stable stage to improve physical fitness and quality of life.</div></div>\",\"PeriodicalId\":10545,\"journal\":{\"name\":\"Complementary therapies in medicine\",\"volume\":\"89 \",\"pages\":\"Article 103152\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Complementary therapies in medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0965229925000275\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Complementary therapies in medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0965229925000275","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}

引用次数: 0

摘要

背景：建议在肺康复中进行体育锻炼干预，以增加慢性阻塞性肺疾病（COPD）患者的力量、耐力和灵活性。然而，某些物理干预可能会限制COPD患者，因为它会引起疲劳和呼吸短促。马王堆运动是一种中低强度的有氧运动，作为一种辅助物理疗法在中国越来越受欢迎，尤其是对有运动禁忌症的患者，以改善他们的健康。目的：探讨中药马王堆运动对COPD轻、中度稳定期患者的治疗效果。方法：共54例稳定期COPD患者(马王堆组，n = 27；对照组27例，为期12周。马王堆组进行马王堆运动，而对照组保持日常活动，没有额外的运动。结果测量为肺功能、运动能力、后腿-胸部肌肉力量、坐伸灵活性、呼吸困难症状和生活质量。在干预后基线、24小时、6周和12周对结果进行评估。结果：Borg CR-10评分、SpO2、BMI、体脂%、脂肪质量、柔韧性mMRC和SGRQ评分（p1、FVC、FEV1% pred）均有改善，无脂质量未见马王堆运动改善。结论：COPD稳定期患者进行马王堆运动12周后，运动能力、呼吸困难、肌力、柔韧性、BMI、体脂率、脂肪量及生活质量均有改善。因此，建议COPD稳定期患者进行马王堆运动，以提高体质和生活质量。试验注册号：ChiCTR2200064390。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Effects of Mawangdui exercise intervention on the pulmonary function, physical fitness and quality of life in stable chronic obstructive pulmonary disease patients: A randomised controlled trial

Background

Physical exercise intervention in pulmonary rehabilitation is recommended to increase strength, endurance, and flexibility in chronic obstructive pulmonary disease (COPD). However, certain physical intervention may be restrictive to COPD patients, as it induces fatigue and shortness of breath. Mawangdui exercise, a low-to-medium-intensity aerobic exercise, has been gaining popularity in China as an adjuvant physical therapy, particularly for patients with contraindications to exercise, to improve their health.

Objective

To investigate the effectiveness of the traditional Chinese Mawangdui exercise for patients with COPD in a mild to moderate stable stage.

Methods

A total of 54 COPD patients in stable stage (Mawangdui group, n = 27; control group, n = 27) were enroled for a period of 12-weeks. The Mawangdui group practised the Mawangdui exercise, while the control group maintained daily activities without additional exercise. The outcomes measurements were pulmonary function, exercise capacity, back-leg-chest muscle strength, sit-and-reach flexibility, dyspnoea symptoms, and quality of life. The outcomes were assessed at baseline, 24 h, 6 weeks, and 12 weeks post-intervention.

Results

Improvements were observed for Borg CR-10 score, SpO₂, BMI, body fat%, fat mass, flexibility mMRC, and SGRQ scores (p < 0.05) at 12 weeks. At week 12, Mawangdui group showed improved exercise capacity (6MWT mean difference 63.39 m, CI 48.36－78.40), back-leg-chest muscle strength (mean difference 5.92 kg, CI −2.57－-14.41), and dyspnoea (CAT score mean difference −5.50, CI −6.42－-4.59) in per-protocol population. However, FEV₁, FVC, FEV₁% pred, and fat-free mass did not show improvements with Mawangdui exercise.

Conclusion

COPD patients in stable stage who performed Mawangdui exercise for 12 weeks improved exercise capacity, dyspnoea, muscle strength, flexibility, BMI, body fat%, fat mass and quality of life. Therefore, Mawangdui exercise is recommended for COPD patients in the stable stage to improve physical fitness and quality of life.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Complementary therapies in medicine 医学-全科医学与补充医学

CiteScore

8.60

自引率

2.80%

发文量

101

审稿时长

112 days

期刊介绍： Complementary Therapies in Medicine is an international, peer-reviewed journal that has considerable appeal to anyone who seeks objective and critical information on complementary therapies or who wishes to deepen their understanding of these approaches. It will be of particular interest to healthcare practitioners including family practitioners, complementary therapists, nurses, and physiotherapists; to academics including social scientists and CAM researchers; to healthcare managers; and to patients. Complementary Therapies in Medicine aims to publish valid, relevant and rigorous research and serious discussion articles with the main purpose of improving healthcare.